|
How to Cite 1. For In-Text Citation (Materials & Methods): 2. For Key Resources Table: |
||
|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. We strive to reply to |
| Formula | C29H34F3N3O6 |
||||||||||
| Molecular Weight | 577.59 | CAS No. | 1262238-11-8 | ||||||||
| Solubility (25°C)* | In vitro | DMSO | 100 mg/mL (173.13 mM) | ||||||||
| Ethanol | 100 mg/mL (173.13 mM) | ||||||||||
| Water | Insoluble | ||||||||||
| In vivo (Add solvents to the product individually and in order) |
|
||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
|||||||||||
| Description | INCB3344 is a potent, selective and orally bioavailable CCR2 antagonist with IC50 values of 5.1 nM (hCCR2) and 9.5 nM (mCCR2) in binding antagonism and 3.8 nM (hCCR2) and 7.8 nM (mCCR2) in antagonism of chemotaxis activity. | ||||
|---|---|---|---|---|---|
| Targets |
|
|
| Loss of TREM2 function in mice leads to blood-brain barrier impairment, pathological leakage, and cognitive deficits due to microglial CCL2 upregulation [ Research Square, January 29, 2024, nan] | PubMed: nan |
| The STAT3–ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer [ Frontiers in Oncology, February 20, 2026, 16:1699471] | PubMed: nan |
| Integrated Multi-Omics Profiling Reveals That Highly Pyroptotic MDMs Contribute to Psoriasis Progression Through CXCL16 [ Biomedicines, 2025, 13(7)1763] | PubMed: 40722833 |
| Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2 [ MedComm (2020), 2024, 5(5):e535] | PubMed: 38741887 |
| Disulfiram treatment suppresses antibody-producing reactions by inhibiting macrophage activation and B cell pyrimidine metabolism [ Commun Biol, 2024, 7(1):488] | PubMed: 38649462 |
| Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma [ Cancer Res, 2023, 83(16):2690-2703] | PubMed: 37249584 |
| The CCL2-CCR2 axis contributes to acquired osimertinib resistance in lung cancer by upregulating Zeb1 expression [ Research Square, 2023, 10.21203/rs.3.rs-3674324/v1] | PubMed: none |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.